2012
DOI: 10.1007/s00113-012-2238-4
|View full text |Cite
|
Sign up to set email alerts
|

Knochenersatz

Abstract: Due to the special characteristics, autologous bone for bone grafting remains the gold standard for defect filling. Besides allogenic bone transplants, as an alternative a set of bone substitutes has been established. An overview of the bone substitutes presently on the market is almost lost due to the abundance of products. The present paper gives a review of the materials available on the market. Different classification systems regarding origin, vitality, biological priority and chemical composition are des… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
5
0
1

Year Published

2013
2013
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(6 citation statements)
references
References 74 publications
0
5
0
1
Order By: Relevance
“…The majority of CaP bioceramics are chemically based on hydroxyapatite (HA), both types of tricalcium phosphate (α-TCP, ß-TCP) and/or their multiphase formulations (Dorozhkin, 2013). Calcium phosphate cements (CPCs) have been commercially available for years and are clinically applied as solids and cement pastes (Dorozhkin, 2008;Rentsch et al, 2012;Lodoso-Torrecilla et al, 2021). However, many CPCs, like most CaPs, have the disadvantage of incomplete degradation over months to years due to a low solubility under physiological conditions (Kurashina et al, 1997;Frakenburg et al, 1998;Bohner et al, 2003;Ambard and Mueninghoff, 2006;Kanter et al, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…The majority of CaP bioceramics are chemically based on hydroxyapatite (HA), both types of tricalcium phosphate (α-TCP, ß-TCP) and/or their multiphase formulations (Dorozhkin, 2013). Calcium phosphate cements (CPCs) have been commercially available for years and are clinically applied as solids and cement pastes (Dorozhkin, 2008;Rentsch et al, 2012;Lodoso-Torrecilla et al, 2021). However, many CPCs, like most CaPs, have the disadvantage of incomplete degradation over months to years due to a low solubility under physiological conditions (Kurashina et al, 1997;Frakenburg et al, 1998;Bohner et al, 2003;Ambard and Mueninghoff, 2006;Kanter et al, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…Allo-or xenografts carry the risk of immunogenic rejection and the potential for disease transmission [2,3]. Artificial matrix materials based on e.g., calcium phosphates, bioglass, synthetic or biological polymers and composites were developed to overcome the drawbacks of auto-, allo-and xenografts [4][5][6][7][8][9]. However, for bone regeneration, the ingrowth of osteogenic cells, as well as blood vessels to ensure sufficient nutrient and oxygen supply, is important.…”
Section: Introductionmentioning
confidence: 99%
“…Bei allogenen Transplantaten werden diese Nachteile vermieden, müssen jedoch gegen die potenzielle Übertragung von Infektionskrankheiten – die allerdings als sehr gering eingeschätzt werden kann 5 – und der fehlenden „osteogenen Potenz“ gegenüber autologer Knochentransplantation abgewogen werden. Zum Risiko der Übertragung von HIV oder Hepatitis C gehen Schätzungen in der Literatur von einer Inzidenzrate bei Gewebespendern von 0,03% für HIV und 0,012% für Hepatitis C aus 6 .…”
Section: Introductionunclassified